Bluejay Diagnostics (BJDX) Cash from Investing Activities (2022 - 2023)

Historic Cash from Investing Activities for Bluejay Diagnostics (BJDX) over the last 2 years, with Q4 2023 value amounting to -$87894.0.

  • Bluejay Diagnostics' Cash from Investing Activities rose 6310.18% to -$87894.0 in Q4 2023 from the same period last year, while for Dec 2023 it was -$704166.0, marking a year-over-year increase of 4128.38%. This contributed to the annual value of -$306783.0 for FY2024, which is 5643.31% up from last year.
  • Bluejay Diagnostics' Cash from Investing Activities amounted to -$87894.0 in Q4 2023, which was up 6310.18% from -$74498.0 recorded in Q3 2023.
  • In the past 5 years, Bluejay Diagnostics' Cash from Investing Activities ranged from a high of -$46346.0 in Q1 2022 and a low of -$791464.0 during Q3 2022